Dual-roadmap guidance for endovascular recanalization of medically refractory non-acute intracranial arterial occlusions: consecutive multicenter series and technical review

医学 耐火材料(行星科学) 外科 血管内治疗 放射科 动脉瘤 天体生物学 物理
作者
Feng Gao,Xu Guo,Xuan Sun,Yan Liu,Yingchun Wu,Zhongrong Miao
出处
期刊:Journal of NeuroInterventional Surgery [BMJ]
卷期号:13 (10): 889-893 被引量:12
标识
DOI:10.1136/neurintsurg-2020-016754
摘要

Background The optimal treatment for medically refractory non-acute intracranial artery occlusion is uncertain, and endovascular recanalization remains a technical challenge. Here, a multicenter clinical experience of dual-roadmap guidance for endovascular recanalization of non-acute intracranial artery occlusion is reported, focusing on the technical feasibility and safety. Methods From January 2014 to December 2019, 52 consecutive patients with medically refractory atherosclerotic non-acute intracranial artery occlusion who underwent endovascular recanalization under dual-roadmap guidance in three large regional referral stroke centers were analyzed retrospectively. Four types of dual-roadmap technical schemes were applied during endovascular recanalization. The rates of technical success, periprocedural complications, any stroke or death within 30 days, and follow-up results were evaluated. Results The technical success rate was 92.3% (48/52). The perioperative complication rate was 7.7% (4/52), and the rate of any stroke or death within 30 days was 3.8% (2/52). Asymptomatic dissection occurred in two patients, acute in-stent thrombosis followed by postoperative mild stroke (National Institutes of Health Stroke Scale (NIHSS) 3) in one patient, and death due to reperfusion hemorrhage after successful recanalization in one patient. The rate of stroke or death beyond 30 days was 6.5% (3/46). The median clinical follow-up period was 19 months, and the median imaging follow-up period was 12 months. The restenosis rate was 13.2% (5/38). Conclusions Endovascular recanalization of non-acute intracranial occlusions can be performed with a high rate of technical success and few complications with assistance of the dual-roadmap technique for navigation. Four types of dual-roadmap schemes provide technical references.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
2秒前
4秒前
6秒前
万能图书馆应助iligll采纳,获得10
6秒前
微笑千愁完成签到 ,获得积分10
7秒前
舒心的飞荷完成签到 ,获得积分10
8秒前
科研通AI6.2应助zhengtan采纳,获得10
8秒前
9秒前
菠萝完成签到 ,获得积分0
10秒前
10秒前
12秒前
13秒前
张辰熙完成签到 ,获得积分10
14秒前
色彩发布了新的文献求助10
14秒前
潇洒的绮山完成签到,获得积分10
15秒前
16秒前
Bethune124完成签到 ,获得积分10
17秒前
还差完成签到,获得积分10
17秒前
ren发布了新的文献求助10
18秒前
azq完成签到,获得积分10
19秒前
香蕉梨愁完成签到,获得积分10
20秒前
隐形的寒香完成签到,获得积分10
21秒前
小事发布了新的文献求助200
21秒前
22秒前
顾矜应助ZD采纳,获得10
22秒前
uracil97完成签到,获得积分10
23秒前
lauren发布了新的文献求助10
24秒前
qq关注了科研通微信公众号
27秒前
32秒前
Zhangnini应助枯蚀采纳,获得20
34秒前
NexusExplorer应助Serein采纳,获得10
35秒前
powerkeg发布了新的文献求助100
36秒前
36秒前
科研通AI6.1应助jewel9采纳,获得10
37秒前
qq发布了新的文献求助10
37秒前
40秒前
LUCHI应助乙酰乙酰CoA采纳,获得10
41秒前
CC66完成签到 ,获得积分10
42秒前
zhujun发布了新的文献求助10
43秒前
Eternity发布了新的文献求助10
44秒前
高分求助中
Clinical Epidemiology: The Essentials, 6e 10000
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
The Graphene Handbook (2019 Edition) 800
Adhesion Science: Principles & Practice 800
Signals, Systems, and Signal Processing 610
Fundamentals of Pharmaceutical and Biologics Regulations: A Global Perspective, Second Edition 600
The Immune System (Fifth Edition) 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 工程类 有机化学 化学工程 生物化学 计算机科学 物理 内科学 复合材料 催化作用 物理化学 光电子学 电极 细胞生物学 基因 无机化学
热门帖子
关注 科研通微信公众号,转发送积分 6568180
求助须知:如何正确求助?哪些是违规求助? 8347779
关于积分的说明 17885285
捐赠科研通 5695137
什么是DOI,文献DOI怎么找? 2944040
邀请新用户注册赠送积分活动 1919936
关于科研通互助平台的介绍 1795942